United States S 1391: Fair Accountability and Innovative Research Drug Pricing Act of 2019

Status: Introduced in Senate (as of 2019-05-09)

State: United States · Session: 116 · Bill: S 1391

Subjects: Civil actions and liability, Congressional oversight, Consumer affairs, Corporate finance and management, Government information and archives, Government studies and investigations, Inflation and prices, Medical research, Prescription drugs, Research and development

Sponsors: Tammy Baldwin, Angus King, John Hoeven, Kevin Cramer, Lisa Murkowski, Mike Braun, Sherrod Brown, Tina Smith

View United States S 1391 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.